rs5928

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 5P and 4B. PS3BS1PP3

This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.2441G>A (p.Arg814Gln) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes BS1, PS3 and PP3 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 30 August 2024. The supporting evidence is as follows: BS1: FAF=0.003604 (0.3604%) in African/African American exomes + genomes (gnomAD v4.1.0). PP3: REVEL=0.768.PS3: Level 1 assay, PMID 37739193 (Mori et al., 2024): Heterologous cells (HepG2 transfected cells with CRISPR/Cas9), FACS, WB, and CLSM assays. FACS: ~40% cell surface LDLR, 6% binding, and 7% uptake; WB: altered expression of LDLR in HepG2 cells transfected ---- results are below 70% of wild-type, consistent with damaging effect. LINK:https://erepo.genome.network/evrepo/ui/classification/CA023671/MONDO:0007750/013

Frequency

Genomes: 𝑓 0.0011 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

LDLR
NM_000527.5 missense

Scores

3
4
6

Clinical Significance

Uncertain significance reviewed by expert panel P:2U:9B:8O:1

Conservation

PhyloP100: 4.12

Publications

18 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PS3
For more information check the summary or visit ClinGen Evidence Repository.
PP3
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
NM_000527.5
MANE Select
c.2441G>Ap.Arg814Gln
missense
Exon 17 of 18NP_000518.1P01130-1
LDLR
NM_001195798.2
c.2441G>Ap.Arg814Gln
missense
Exon 17 of 18NP_001182727.1P01130-5
LDLR
NM_001195799.2
c.2318G>Ap.Arg773Gln
missense
Exon 16 of 17NP_001182728.1P01130-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
ENST00000558518.6
TSL:1 MANE Select
c.2441G>Ap.Arg814Gln
missense
Exon 17 of 18ENSP00000454071.1P01130-1
LDLR
ENST00000252444.10
TSL:1
c.2699G>Ap.Arg900Gln
missense
Exon 17 of 18ENSP00000252444.6J3KMZ9
LDLR
ENST00000558013.5
TSL:1
c.2441G>Ap.Arg814Gln
missense
Exon 17 of 18ENSP00000453346.1P01130-5

Frequencies

GnomAD3 genomes
AF:
0.00111
AC:
168
AN:
151912
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00384
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000526
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000259
AC:
65
AN:
251446
AF XY:
0.000162
show subpopulations
Gnomad AFR exome
AF:
0.00351
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000121
AC:
177
AN:
1461820
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
88
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.00412
AC:
138
AN:
33480
American (AMR)
AF:
0.000179
AC:
8
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53384
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000719
AC:
8
AN:
1111988
Other (OTH)
AF:
0.000364
AC:
22
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00111
AC:
169
AN:
152030
Hom.:
2
Cov.:
31
AF XY:
0.00104
AC XY:
77
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.00386
AC:
160
AN:
41476
American (AMR)
AF:
0.000525
AC:
8
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10574
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67990
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000439
Hom.:
0
Bravo
AF:
0.00142
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000280
AC:
34
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
4
2
Hypercholesterolemia, familial, 1 (8)
-
4
1
not provided (6)
-
-
2
Familial hypercholesterolemia (2)
-
-
2
not specified (2)
-
-
1
Cardiovascular phenotype (1)
-
1
-
Hypercholesterolemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.036
T
BayesDel_noAF
Pathogenic
0.24
CADD
Uncertain
25
DANN
Uncertain
1.0
Eigen
Uncertain
0.36
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.33
T
M_CAP
Pathogenic
0.74
D
MetaRNN
Benign
0.089
T
PhyloP100
4.1
PROVEAN
Benign
1.1
N
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.17
T
Vest4
0.79
MVP
1.0
ClinPred
0.027
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.18
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5928; hg19: chr19-11240240; API